Mogrify to present preclinical data for retinal reprogramming
Mogrify will present preclinical proof-of-concept data for an in vivo retinal reprogramming therapy at the FLORetina-ICOOR 2026 Congress, scheduled for December 3–6, 2026, with the presentation set for December 3, 2026, 12:00–13:00. The post Mogrify to present preclinical data for retinal reprogramm
<p>Mogrify will present preclinical proof-of-concept data for an in vivo retinal reprogramming therapy at the FLORetina-ICOOR 2026 Congress, scheduled for December 3–6, 2026, with the presentation set for December 3, 2026, 12:00–13:00.
The post Mogrify to present preclinical data for retinal reprogramm</p>